Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing clinical safety registration study of Sanwu capsules
ChiCTR2100044852Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Sanwu capsules, sponsored by Xiangya Hospital, Central South University. Primary endpoint: Alanine aminotransferase. Started Mar 2021; status: recruiting.
02
Drugs
Sanwu capsules
Beyond the preview
Go deeper on ChiCTR2100044852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044852.